The U.S. medical cannabis market is expected to be valued at USD 19.48 billion by 2024, driven by its numerous medical benefits particularly by patients suffering from cancer, chronic pain and diabetes. Favorable regulatory environment across numerous states including California and Colorado is expected to fuel the growth of the market over the next few years.
Medical Marijuana Regulation and Safety Act implemented in 2015 permits the cultivation and use of cannabis dispensaries at the state and local level which has been one of key drivers to fuel the U.S market. The rising number of states receiving approval to utilize cannabis for consumption in medical cases is expected to be one of the crucial factors to upsurge the demand for medical marijuana over the forecast period.
Over the past few decades, there have been several controversies surrounding legalization of cannabis for medical purposes; however, increasing signs of medical benefits received from the consumption of cannabis has resulted in the herb being legalized across various states in the nation. The industry is expected to witness significant growth during the forecast period owing to greater consumer acceptance along with an increasing number of companies entering the market.
The symptoms and conditions that can be treated by the herb include cancer, arthritis, epilepsy, nausea, pain Alzheimer’s disease, anorexia, AIDS, HIV, glaucoma, cachexia, Crohn’s disease, migraines, and multiple sclerosis. Chronic pain accounted for 46% of the U.S. cannabis medical market share in 2016. The ability of medical marijuana to curb pain is expected to gain popularity among patients diagnosed with chronic illnesses and pain.
In 2016, solid edibles segment dominated the U.S market generating revenues worth USD 2.47 billion and is expected to continue dominating the industry over the forecast period. The future product innovation and potential growth are substantial owing to continuous development from the consumption of cannabis infused products owing to their numerous applications including lotions, bath salts, shampoo, lip balm, toothpaste, coffee pods, baked brownies cookies, candy, confectioneries, beverages, vinegar and oils.
California is known to be the first state in U.S. that legalized cannabis for medical purpose. In 2016, California recorded the highest revenue generation and is expected to grow at a CAGR of 13% over the projected period. Over the next few years, more number of state governments are expected to legalize cannabis owing to its numerous benefits which will fuel its growth over the projected period.
PLEASE NOTE: This report will be dispatched approximately 1-2 business days after the confirmation of payment.
1.1. Market trends & movement
Chapter 2. U.S. Medical Cannabis Market Trends: Drivers & Opportunities
2.2. Key industry trends
2.3. Market drivers
2.4. Market restraints
2.5. Value chain analysis
2.6. Porter's Five Forces analysis
Chapter 3. U.S. Medical Cannabis Market Trends, By Usage
3.1. U.S. Medical Cannabis market movement, by usage, 2016 & 2024
3.1.1. Chronic Pain
126.96.36.199. Market estimates and forecast, 2014-2024 (USD Million)
188.8.131.52. Market estimates and forecast, 2014-2024 (USD Million)
184.108.40.206. Market estimates and forecast, 2014-2024 (USD Million)
220.127.116.11. Market estimates and forecast, 2014-2024 (USD Million)
18.104.22.168. Market estimates and forecast, 2014-2024 (USD Million)
Chapter 4. U.S. Medical Cannabis Market Trends, By Consumption
4.1. U.S. Medical Cannabis market movement, by consumption, 2016 & 2024
4.1.1. Solid edibles
22.214.171.124. Market estimates and forecast, 2014-2024 (USD Million)
126.96.36.199. Market estimates and forecast, 2014-2024 (USD Million)
4.1.3. Liquid edibles
188.8.131.52. Market estimates and forecast, 2014-2024 (USD Million)
184.108.40.206. Market estimates and forecast, 2014-2024 (USD Million)
Chapter 5. U.S. Medical Cannabis Market Trends, By State
5.1. U.S. Medical Cannabis market movement, by state, 2016 & 2024
220.127.116.11. Market estimates and forecast, 2014-2024 (USD Million)
18.104.22.168. Market estimates and forecast, 2014-2024 (USD Million)
22.214.171.124. Market estimates and forecast, 2014-2024 (USD Million)
126.96.36.199. Market estimates and forecast, 2014-2024 (USD Million)
188.8.131.52. Market estimates and forecast, 2014-2024 (USD Million)
Chapter 6. Competitive Landscape
6.1. Competitive landscape analysis, 2016
6.2. Strategic framework
6.3. Potential customer base concentration
6.4. Company market positioning
6.5. Company profiles
6.5.1. American Cannabis
184.108.40.206. Company Overview
220.127.116.11. Product Benchmarking
18.104.22.168. Financial Performance
22.214.171.124. Recent Initiatives
6.5.2. Canopy Growth Corporation
126.96.36.199. Company Overview
188.8.131.52. Product Benchmarking
184.108.40.206. Financial Performance
220.127.116.11. Recent Initiatives
6.5.3. Greengro Technologies
18.104.22.168. Company Overview
22.214.171.124. Product Benchmarking
126.96.36.199. Financial Performance
188.8.131.52. Recent Initiatives
6.5.4. Medical Marijuana Inc.
184.108.40.206. Company Overview
220.127.116.11. Product Benchmarking
18.104.22.168. Financial Performance
22.214.171.124. Recent Initiatives
6.5.5. United Cannabis
126.96.36.199. Company Overview
188.8.131.52. Product Benchmarking
184.108.40.206. Financial Performance
220.127.116.11. Recent Initiatives
6.5.6. Terra Tech Corp.
18.104.22.168. Company Overview
22.214.171.124. Product Benchmarking
126.96.36.199. Financial Performance
188.8.131.52. Recent Initiatives
6.5.7. Mentor Capital, Inc
184.108.40.206. Company Overview
220.127.116.11. Product Benchmarking
18.104.22.168. Financial Performance
22.214.171.124. Recent Initiatives
6.5.8. Cannabis Sativa, Inc.
126.96.36.199. Company Overview
188.8.131.52. Product Benchmarking
184.108.40.206. Financial Performance
220.127.116.11. Recent Initiatives
6.5.9. GBSciences, Inc
18.104.22.168. Company Overview
22.214.171.124. Product Benchmarking
126.96.36.199. Financial Performance
188.8.131.52. Recent Initiatives
6.5.10. The Green Solution.
184.108.40.206. Company Overview
220.127.116.11. Product Benchmarking
18.104.22.168. Financial Performance
22.214.171.124. Recent Initiatives
6.5.11. List of other vendors
Chapter 7. Methodology and Scope
7.1. Research methodology
7.2. Research Scope & Assumptions
7.3. List of data sources
*Full List of Tables & Figures Available on Enquiry.
- American Cannabis
- Canopy Growth Corporation
- Greengro Technologies
- Medical Marijuana Inc.
- United Cannabis
- Terra Tech Corp.
- Mentor Capital, Inc
- Cannabis Sativa, Inc.
- GBSciences, Inc
- The Green Solution.